| OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection | — | Optain Health | <1 mi |
| Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) | Phase 3 | Viking Therapeutics, Inc. | <1 mi |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis | Phase 2/3 | CSL Behring | <1 mi |
| Project Dulce for Filipino-Americans With Type 2 Diabetes | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| Dosimetry of Tc-99m-Tilmanocept | Phase 1 | University of California, San Diego | <1 mi |
| GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes | N/A | Medtronic Diabetes | <1 mi |
| Enhancing Digitally Delivered Diabetes Education With Real-Time CGM | N/A | Scripps Whittier Diabetes Institute | <1 mi |
| Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone | N/A | Capsicure, LLC | <1 mi |
| Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes | N/A | University of California, San Diego | <1 mi |
| A Study of GNTI-122 in Adults Recently Diagnosed With T1D | Phase 1 | GentiBio, Inc | <1 mi |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) | Phase 1/2 | COUR Pharmaceutical Development Company, Inc. | <1 mi |
| A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin | Phase 3 | Eli Lilly and Company | <1 mi |
| Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults | N/A | San Diego State University | <1 mi |
| Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population | N/A | San Diego State University | <1 mi |
| Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) | — | Jaeb Center for Health Research | <1 mi |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes | Phase 3 | Novo Nordisk A/S | <1 mi |
| More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus | N/A | University of California, San Diego | <1 mi |
| Efficacy of Using Mobile Health Applications for Health | N/A | San Diego State University | <1 mi |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | Phase 3 | Boehringer Ingelheim | <1 mi |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | Phase 2 | Children's Oncology Group | <1 mi |
| ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes | Phase 2 | Scripps Whittier Diabetes Institute | <1 mi |
| Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes | Phase 3 | vTv Therapeutics | <1 mi |
| CGM for Management of Type 2 Diabetes in Pregnancy | N/A | University of Alabama at Birmingham | <1 mi |
| North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) | — | Columbia University | <1 mi |
| Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes | Phase 4 | VA Office of Research and Development | <1 mi |
| Implementing Food Referrals for Equity and Sustained Health | Phase 2 | University of California, San Diego | <1 mi |
| MiniMed Fit Payload Wear Study | — | Medtronic Diabetes | 7 mi |
| Different Doses of Naronapride Vs. Placebo in Gastroparesis | Phase 2 | Dr. Falk Pharma GmbH | 7 mi |
| A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus | Phase 2 | Alnylam Pharmaceuticals | 7 mi |
| A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus | Phase 1 | Amgen | 7 mi |
| Latinos Understanding the Need for Adherence in Diabetes Using E-Health | N/A | San Diego State University | 7 mi |
| Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003) | Phase 1 | Merck Sharp & Dohme LLC | 7 mi |
| A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 | Phase 1 | Portal Diabetes, Inc. | 7 mi |
| Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus | Phase 2 | Hanmi Pharmaceutical Company Limited | 7 mi |
| A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) | Phase 1 | Merck Sharp & Dohme LLC | 7 mi |
| A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events | N/A | Cleerly, Inc. | 7 mi |
| Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) | Phase 2 | Sparrow Pharmaceuticals | 9 mi |
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Phase 3 | Eli Lilly and Company | 10 mi |
| A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin | Phase 2 | Eli Lilly and Company | 10 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 10 mi |
| A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes | Phase 2 | Hoffmann-La Roche | 10 mi |
| Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7 | N/A | Scripps Whittier Diabetes Institute | 11 mi |
| Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide | Phase 3 | Novo Nordisk A/S | 11 mi |
| Closed Loop and Education for Hypoglycemia Awareness Restoration | N/A | Milton S. Hershey Medical Center | 11 mi |
| Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes | N/A | University of California, San Diego | 11 mi |
| Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health | Phase 2 | University of California, San Diego | 11 mi |
| Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes | Phase 1/2 | University of California, San Diego | 11 mi |
| Time-Restricted Eating for Type II Diabetes: TRE-T2D | N/A | University of California, San Diego | 11 mi |
| THC Effects on Glucose in Type 2 Diabetes | Phase 1 | University of California, San Diego | 11 mi |
| A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome | Phase 3 | NewAmsterdam Pharma | 11 mi |
| Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial | Phase 2 | University of California, San Diego | 11 mi |
| Project Dulce for Arab Americans With Type 2 Diabetes | N/A | Scripps Whittier Diabetes Institute | 13 mi |
| A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes | Phase 2 | Zucara Therapeutics Inc. | 28 mi |
| Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature | N/A | Senseonics, Inc. | 28 mi |
| Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes | Phase 3 | Kailera | 28 mi |
| Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes | Phase 3 | Kailera | 28 mi |
| Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM | N/A | i-SENS, Inc. | 28 mi |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes | Phase 3 | Eli Lilly and Company | 28 mi |
| A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's | N/A | Compedica Inc | 34 mi |
| Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers | N/A | LifeNet Health | 34 mi |
| Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management | N/A | Legacy Medical Consultants | 34 mi |
| Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | N/A | Piomic Medical | 34 mi |
| EDX110 Randomized Control Trial for Treatment of DFUs | N/A | ConvaTec Inc. | 34 mi |
| Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers | N/A | Tides Medical | 34 mi |
| Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC | N/A | Surgenex | 34 mi |
| Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes | Phase 3 | Kailera | 36 mi |